Back to dataset
National Oesophago-Gastric Cancer Audit, 2017
You're previewing the first 4 rows of this file.
Download this fileAudit year(s) | Cancer Alliance code | Cancer Alliance name | N First diagnosis confirmed by second pathologist | % First diagnosis confirmed by second pathologist | N Quadratic biopsy performed | % Quadratic biopsy performed | N HGD plan discussed at MDT | % HGD plan discussed at MDT | N Treatment plan for active treatment | % Treatment plan for active treatment | N Surveillance/no active treatment | % Surveillance/no active treatment | N Curative surgical resection | % Curative surgical resection | N Endoscopic treatment | % Endoscopic treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr 2012 - Mar 2016 | A01 | Cheshire and Merseyside | 48 | 76.2% | 10 | 43.5% | 51 | 63.0% | 57 | 74.0% | 20 | 26% | 4 | 5% | 53 | 69% |
Apr 2012 - Mar 2016 | A02 | East Midlands | 125 | 96.2% | 13 | 72.2% | 128 | 94.1% | 105 | 79.5% | 27 | 20% | 2 | 2% | 103 | 78% |
Apr 2012 - Mar 2016 | A03 | East of England | 167 | 90.3% | 44 | 86.3% | 170 | 95.0% | 138 | 81.7% | 31 | 18% | 2 | 1% | 136 | 80% |
Apr 2012 - Mar 2016 | A04 | Greater Manchester | 70 | 90.9% | 30 | 85.7% | 102 | 91.1% | 75 | 75.0% | 25 | 25% | 5 | 5% | 70 | 70% |